MedPath

HIV/STD Safer Sex Skills Groups for Men in Drug Treatment Programs - 1

Phase 3
Completed
Conditions
Behavior Therapy
Registration Number
NCT00084175
Lead Sponsor
University of Washington
Brief Summary

The purpose of this study is to evaluate a five-session Human Immunodeficiency Virus/Acquired Immune Deficiency Disease (HIV/AIDS) group therapy designed specifically for heterosexual men. This therapy is compared to standard HIV/AIDS education, which generally consists of a single session of HIV education.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
630
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
AIDS risk behavior
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (14)

Matrix Institute on Addictions

πŸ‡ΊπŸ‡Έ

Rancho Cucamonga, California, United States

San Francisco General Hospital

πŸ‡ΊπŸ‡Έ

San Francisco, California, United States

Hartford Dispensary

πŸ‡ΊπŸ‡Έ

New Britain, Connecticut, United States

CT Renaissance, Inc.

πŸ‡ΊπŸ‡Έ

Norwalk, Connecticut, United States

Life Link

πŸ‡ΊπŸ‡Έ

Santa Fe, New Mexico, United States

Staten Island University Hospital

πŸ‡ΊπŸ‡Έ

Staten Island, New York, United States

Addiction Drug Services-Highpoint

πŸ‡ΊπŸ‡Έ

High Point, North Carolina, United States

South Light

πŸ‡ΊπŸ‡Έ

Raleigh, North Carolina, United States

Comprehensive Addiction Services System

πŸ‡ΊπŸ‡Έ

Toledo, Ohio, United States

The Consortium

πŸ‡ΊπŸ‡Έ

Philadelphia, Pennsylvania, United States

Scroll for more (4 remaining)
Matrix Institute on Addictions
πŸ‡ΊπŸ‡ΈRancho Cucamonga, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.